Brief: Organogenesis Holdings Inc. Reports Fourth Quarter And Fiscal Year 2020 Financial Results Introduces Fiscal Year 2021 Guidance
16/03/2021 23:03
March 16 (Reuters) - Organogenesis Holdings Inc ORGO.O :
* . REPORTS FOURTH QUARTER AND FISCAL YEAR 2020 FINANCIAL
RESULTS;
INTRODUCES FISCAL YEAR 2021 GUIDANCE
* Q4 EARNINGS PER SHARE $0.16
* Q4 REVENUE $106.8 MILLION VERSUS REFINITIV IBES ESTIMATE
OF
$93.1 MILLION
* SEES FY 2021 REVENUE $390 MILLION TO $405 MILLION
* Q4 EARNINGS PER SHARE ESTIMATE $0.07 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNXST7Mc
Further company coverage: ORGO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers